The Combination of Hereditary Elliptocytosis with Heterozygous Beta-Thalassaemia

Muzaffer Aksoy

doi:10.1159/000208126

The Combination of Hereditary Elliptocytosis with Heterozygous Beta-Thalassaemia

Acta Haematologica ◽

10.1159/000208126 ◽

1963 ◽

Vol 30 (4) ◽

pp. 215-220 ◽

Cited By ~ 7

Author(s):

Muzaffer Aksoy

Keyword(s):

Hereditary Elliptocytosis ◽

Beta Thalassaemia

Download Full-text

Combination of hereditary elliptocytosis and heterozygous beta-thalassaemia: a family study.

Journal of Medical Genetics ◽

10.1136/jmg.5.4.298 ◽

1968 ◽

Vol 5 (4) ◽

pp. 298-301 ◽

Cited By ~ 10

Author(s):

M Aksoy ◽

S Erdem

Keyword(s):

Family Study ◽

Hereditary Elliptocytosis ◽

Beta Thalassaemia

Download Full-text

Hereditary Elliptocytosis Associated with Beta-Thalassaemia and a Variant of Rh (D)

Acta Haematologica ◽

10.1159/000208580 ◽

1971 ◽

Vol 46 (4) ◽

pp. 232-241 ◽

Cited By ~ 5

Author(s):

N. Nagaratnam ◽

K.A. Siripala ◽

A.M.P. Attapatu ◽

J.V. Undevia ◽

P.K. Sukumaran

Keyword(s):

Hereditary Elliptocytosis ◽

Beta Thalassaemia

Download Full-text

Risk factors associated with osteoporosis in beta-thalassaemia major patients

Endocrine Abstracts ◽

10.1530/endoabs.49.ep307 ◽

2017 ◽

Author(s):

Elena Mirela Iancu ◽

Alice Ioana Albu ◽

Irina Nicolaescu

Keyword(s):

Risk Factors ◽

Thalassaemia Major ◽

Factors Associated ◽

Beta Thalassaemia

Download Full-text

Orphan designation: 2-(2-{[2-(1H-benzimidazol-2-yl)ethyl]amino}ethyl)-N-[(3-fluoropyridine-2-yl)methyl]-1,3-oxazole-4-carboxamide trihydrochloride, Treatment of beta-thalassaemia intermedia and major

Case Medical Research ◽

10.31525/cmr-1e36742 ◽

2019 ◽

Author(s):

Keyword(s):

Orphan Designation ◽

Beta Thalassaemia ◽

Thalassaemia Intermedia

Download Full-text

Orphan designation: Synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues, Treatment of beta-thalassaemia intermedia and major

Case Medical Research ◽

10.31525/cmr-ea7c31 ◽

2019 ◽

Author(s):

Keyword(s):

Orphan Designation ◽

Beta Thalassaemia ◽

Covalently Linked ◽

Thalassaemia Intermedia ◽

Sirna Oligonucleotide

Download Full-text

Orphan designation: human apotransferrin, Treatment of beta-thalassaemia intermedia and major

Case Medical Research ◽

10.31525/cmr-bb17bc ◽

2019 ◽

Author(s):

Keyword(s):

Orphan Designation ◽

Beta Thalassaemia ◽

Thalassaemia Intermedia

Download Full-text

Orphan designation: Synthetic double-stranded siRNA oligonucleotide directed against TMPRSS6 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues, Treatment of beta-thalassaemia intermedia and major

Case Medical Research ◽

10.31525/cmr-ea2d19 ◽

2019 ◽

Author(s):

Keyword(s):

Orphan Designation ◽

Beta Thalassaemia ◽

Covalently Linked ◽

Thalassaemia Intermedia ◽

Sirna Oligonucleotide

Download Full-text

Orphan designation: Autologous CD34+ haematopoietic stem cells transduced with lentiviral vector encoding the human betaA-T87Q-globin gene, Treatment of beta thalassaemia intermedia and major

Case Medical Research ◽

10.31525/cmr-de550e ◽

2019 ◽

Author(s):

Keyword(s):

Stem Cells ◽

Lentiviral Vector ◽

Globin Gene ◽

Haematopoietic Stem Cells ◽

Orphan Designation ◽

Beta Thalassaemia ◽

Gene Treatment ◽

Thalassaemia Intermedia

Download Full-text

Orphan designation: human apotransferrin, Treatment of beta-thalassaemia intermedia and major

Case Medical Research ◽

10.31525/cmr-bc10f9 ◽

2019 ◽

Author(s):

Keyword(s):

Orphan Designation ◽

Beta Thalassaemia ◽

Thalassaemia Intermedia

Download Full-text

Faculty Opinions recommendation of Human parvovirus 4 in Brazilian patients with haemophilia, beta-thalassaemia major and volunteer blood donors.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727211487.793527457 ◽

2017 ◽

Author(s):

Paul Klenerman

Keyword(s):

Blood Donors ◽

Thalassaemia Major ◽

Beta Thalassaemia

Download Full-text